OptimiTM-03.jpg
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
March 28, 2024 07:30 ET | Optimi Health Corp.
Optimi Health secures Presenting Sponsorship at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston, MA.
PasitheaLogo.png
Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004
June 29, 2023 08:29 ET | Pasithea
PALO ALTO, Calif. and MIAMI, June 29, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research,...
Gaia-Biomedicine-TreeFrog-Therapeutics-collaboration-allogeneic-NK-cell-therapy-solid-tumors-2023
GAIA BioMedicine and TreeFrog Therapeutics Announce Collaboration for the Expansion of Allogeneic NK-like Cells Against Solid Tumors
February 15, 2023 10:00 ET | TreeFrog Therapeutics
FUKUOKA, Japan and BORDEAUX, France, Feb. 15, 2023 (GLOBE NEWSWIRE) -- GAIA BioMedicine, a Japan-based clinical-stage company pioneering allogeneic NK-like cell therapies against solid tumors, and...
Forecyte CGMP Facility Grand Opening Ribbon Cutting
Forecyte Bio's Grand Opening of the CGMP Facility in Maryland
January 17, 2023 06:00 ET | Forecyte Bio
FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Forecyte Bio, a new global leader in cell and gene therapy contract development and manufacturing, officially opened its 17,000 square feet,...
3.png
Revolutionary progress made in the inaugural year of the Panacea Cannabinoid Research Center at Colorado State University
October 26, 2022 11:57 ET | Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) (“Panacea” or the “Company”), a Colorado, USA-based cannabinoid research and certified GMP...
Logo.jpg
Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development
March 01, 2022 09:15 ET | Invectys, Inc.
Houston, Texas, USA, March 01, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to...
Aldevron Releases GM
Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease
March 12, 2019 08:05 ET | Aldevron
FARGO, ND, March 12, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease...
Novacap to expand it
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
June 20, 2018 12:03 ET | PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
PCI Synthesis Identi
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
December 18, 2017 09:15 ET | PCI Synthesis
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...